ATE533471T1 - Verfahren zur herstellung von schnell auflösenden tabletten - Google Patents

Verfahren zur herstellung von schnell auflösenden tabletten

Info

Publication number
ATE533471T1
ATE533471T1 AT08719894T AT08719894T ATE533471T1 AT E533471 T1 ATE533471 T1 AT E533471T1 AT 08719894 T AT08719894 T AT 08719894T AT 08719894 T AT08719894 T AT 08719894T AT E533471 T1 ATE533471 T1 AT E533471T1
Authority
AT
Austria
Prior art keywords
mixture
fast
fast dissolving
active component
sugar alcohol
Prior art date
Application number
AT08719894T
Other languages
English (en)
Inventor
Zebunnissa Ramtoola
Ritesh Pabari
John Kelly
Original Assignee
Royal College Surgeons Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38436760&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE533471(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Royal College Surgeons Ireland filed Critical Royal College Surgeons Ireland
Application granted granted Critical
Publication of ATE533471T1 publication Critical patent/ATE533471T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
AT08719894T 2007-04-03 2008-04-03 Verfahren zur herstellung von schnell auflösenden tabletten ATE533471T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07394008A EP1977734A1 (de) 2007-04-03 2007-04-03 Verfahren zur Herstellung schnelllöslicher Tabletten
US92231307P 2007-04-09 2007-04-09
PCT/IE2008/000036 WO2008120181A2 (en) 2007-04-03 2008-04-03 A method of producing fast dissolving tablets

Publications (1)

Publication Number Publication Date
ATE533471T1 true ATE533471T1 (de) 2011-12-15

Family

ID=38436760

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08719894T ATE533471T1 (de) 2007-04-03 2008-04-03 Verfahren zur herstellung von schnell auflösenden tabletten

Country Status (10)

Country Link
US (1) US20100074948A1 (de)
EP (2) EP1977734A1 (de)
JP (1) JP2010523552A (de)
CN (1) CN101720219A (de)
AT (1) ATE533471T1 (de)
AU (1) AU2008234511A1 (de)
CA (1) CA2682670A1 (de)
IL (1) IL201304A0 (de)
WO (1) WO2008120181A2 (de)
ZA (1) ZA200907685B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2205213A2 (de) * 2007-10-01 2010-07-14 Laboratorios Lesvi, S.L. Im mund dispergierbare tabletten
WO2010077878A1 (en) * 2008-12-15 2010-07-08 Fleming And Company, Pharmaceuticals Rapidly dissolving vitamin formulation and methods of using the same
WO2010109019A1 (en) * 2009-03-26 2010-09-30 Royal College Of Surgeons In Ireland Orodispersible tablets
JP6072778B2 (ja) * 2011-05-23 2017-02-01 シーイーエム—１０２ ファーマシューティカルズ，インコーポレイテッド フシジン酸を含む組成物およびそのためのパッケージ
EP3206671B1 (de) 2014-10-16 2024-06-12 Cargill, Incorporated Verfahren zur herstellung eines direkt komprimierbaren erythritols und verwendungen davon
CN106310229A (zh) * 2015-06-30 2017-01-11 深圳翰宇药业股份有限公司 一种马昔瑞林薄膜衣片及其制备方法
MX389290B (es) 2015-07-09 2025-03-20 Uniwell Laboratories Llc Composiciones farmacéuticas.
GB2546513B (en) * 2016-01-20 2020-09-16 Cubic Pharmaceuticals Ltd Process of preparing active pharmaceutical ingredient salts
CN105878300B (zh) * 2016-04-11 2020-04-07 浙江工业大学 一种药物速溶片的制备方法
CN108853041A (zh) * 2018-08-20 2018-11-23 益奇健康科技（上海）有限公司 一种口腔速崩片
WO2021137225A1 (en) * 2020-01-02 2021-07-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Floating drug delivery systems comprising cannabinoids
WO2022017864A1 (en) * 2020-07-24 2022-01-27 Dsm Ip Assets B.V. New fast dissolvable tablets
CN112352857A (zh) * 2020-09-28 2021-02-12 苏州蓝浅信息科技有限公司 一种速溶茶片剂及其制备方法
CN116490194A (zh) * 2020-10-30 2023-07-25 帝斯曼知识产权资产管理有限公司 含hmo的非泡腾可溶性片剂
CN115251221A (zh) * 2022-08-02 2022-11-01 青海大学 一种树莓咀嚼片及其制备方法
IL296690B2 (en) * 2022-09-21 2024-12-01 Empire Drying Services LLC Rescue compositions for hypoglycemia

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4517179A (en) * 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
US5178878A (en) * 1989-10-02 1993-01-12 Cima Labs, Inc. Effervescent dosage form with microparticles
JP3797387B2 (ja) * 1996-06-14 2006-07-19 協和醗酵工業株式会社 口腔内速崩壊錠
US6024981A (en) * 1997-04-16 2000-02-15 Cima Labs Inc. Rapidly dissolving robust dosage form
WO2003080023A2 (en) * 2002-03-20 2003-10-02 Elan Pharma International Limited Fast dissolving dosage forms having reduced friability
US20030185884A1 (en) * 2002-04-01 2003-10-02 Singh Nikhilesh Nihala Therapeutic agent delivery compositions for buccal cavity absorption of pilocarpine
US20060083786A1 (en) * 2004-07-29 2006-04-20 Glenmark Pharmaceuticals Limited Taste masking pharmaceutical composition containing levocetirizine
WO2006133349A2 (en) * 2005-06-08 2006-12-14 Alpharma, Inc. Orally disintegrable sleep aid formulations

Also Published As

Publication number Publication date
JP2010523552A (ja) 2010-07-15
EP2142170A2 (de) 2010-01-13
AU2008234511A1 (en) 2008-10-09
EP2142170B1 (de) 2011-11-16
IL201304A0 (en) 2010-05-31
WO2008120181A4 (en) 2009-02-19
EP1977734A1 (de) 2008-10-08
WO2008120181A3 (en) 2008-11-27
ZA200907685B (en) 2010-07-28
CN101720219A (zh) 2010-06-02
CA2682670A1 (en) 2008-10-09
WO2008120181A2 (en) 2008-10-09
US20100074948A1 (en) 2010-03-25

Similar Documents

Publication Publication Date Title
ATE533471T1 (de) Verfahren zur herstellung von schnell auflösenden tabletten
ES2525720T3 (es) Forma de dosificación robusta de disolución rápida
RU2010128380A (ru) Способ получения кондитерского изделия
CO4990940A1 (es) Procedimiento para fabricar tabletas de dispersion por mordedura
RU2010107188A (ru) Микронизация полиолов
JP2006077018A5 (de)
RU2003102625A (ru) Композиция, включающая тонкодисперсные частицы с замедленным высвобождением для быстроразлагающихся в щечной полости таблеток, и способ ее получения
WO2008118133A3 (en) Silk microspheres for encapsulation and controlled release
PT1166776E (pt) Processo para a preparacao de formas de apresentacao farmaceutica orais solidas com libertacao retardada da substancia activa
WO2008052033A3 (en) Ibuprofen composition
WO2010025931A3 (en) Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2 -methyl-propyl) - phenol and an antiepileptic
EA201170695A1 (ru) Улучшенная стабильность таблеток карбоната кальция при растворении
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
WO2004064752A3 (en) Method of preparing sustained release microparticles
CR9292A (es) Comprimidos con dispersion mejorada de la sustancia farmacologica
AR067084A1 (es) Dispersion solida que contiene revaprazan y procedimiento para la preparacion de la misma. composicion farmaceutica.
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
RU2011112926A (ru) Способ изготовления таблеток цетиризина
WO2002067846A8 (en) A vaccine composition and method of using the same
WO2008087323A3 (fr) Forme galenique pour l'administration par voie trans-muqueuse de paracetamol
WO2008021858A3 (en) Process for manufacturing lactose
SI1773292T1 (sl) Hitro razgradljiva oralno disperzibilna farmacevtska oblika
WO2009135950A3 (en) Process for preparing a tablet containing excipients
ATE309788T1 (de) Mikropartikel mit verbessertem freisetzungsprofil und verfahren zu deren herstellung
AR074330A1 (es) Nuevo procedimiento para la preparacion de granulos de principios activos y granulos asi obtenidos